In 2018/20, RYSE DigitalHealth.London investment programmes translated great ideas into real world solutions by partnering with healthcare founders with clinical experience who know how to serve patients best.
DigitalHealth.London is a collaborative programme delivered by MedCity and London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network. It is supported and sponsored by NHS England and the Mayor of London’s Office.
DigitalHealth.London Accelerator is a programme that aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. Programme companies include Huma and Babylon Health.
HELP FOUNDERS GO FURTHER
RYSE invests in early stage companies (Pre-Seed to Series B) that can grow across multiple markets, obtain a defensible market-leading position, and will deliver sustainable impact. Companies are beginning to develop traction in the market and are looking to raise between £100,000 and £5,000,000.